Thai Stock Market Roundup January 22, 2019
A short summary to inform you of what had happened in Thai stock market on January 22, 2019.
23 ม.ค. 2562

– SCC invested ฿131 million to take 100% in TPT and BIFC for seamless logistics services.
– CMAN joined two German partners, established a new subsidiary to develop, manufacture and sell construction materials in Thailand as well as to export to other countries in Southeast Asia.
– GPSC invested ฿24 billion to take over TOP’s “Energy Recovery Unit,” expecting PAC in 2023.
– SCI entered into a joint venture with Gold Elite Paris (Thailand) to establish a cell phone trading and leasing company.
– KTB recorded a 27% growth in 2018 with ฿28.4 billion of profit, supported by loan growth.
– TMB showed robust growth of profit at 34%, reaching ฿11.6 billion in 2018 after non-interest income soared 85.3%.
– An epic fail of “The Marvel Experience,” DCORP set a termination date on January 29, 2019.
– GULF issued four series of debentures not exceeding ฿7.5 billion to offer major investors on January 23-24, 2019.
– DTC acquired 70% of “Epicure Catering” to strengthen its international F&amp;B business.
– Cabinet agreed with medical supplies Price Control Policy, sent negative sentiment to hospital stocks.
– CRD acquired a construction project, Innovative Food Fabrication Pilot Plant, from Science and Technology Park, Chiangmai University with a total project value of ฿145 million.
– CAZ closed flat at ฿3.90/share, the same price as its IPO and also the highest price of the day on its first trading day in mai. The surge of buying came in the afternoon after the share plunged as much as ฿3.60/share in the morning session.
– Local institutions continued to lift the market with ฿1.29 billion buy, sent SET index to close above 1,600 points.
– SET soared above 1,600 points to close at 1,601.77, jumped 13.39 points or 0.84% with ฿49.2 billion in value. Unlike Asia markets, SET hiked almost 1%, supported by PTT and BDMS for the two highest impact shares to SET index.
The cabinet has agreed with the Central Committee on Prices of Goods and Services Price to put medical supplies, services, and drugs on price control policy from 2019 onwards. However, the investors had come to understand that the government would not be the determiner of the price, but to control the price not to go above or below the actual price.
 
Top 10 Most Impact Shares on January 22, 2019
